Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / COM STK CL A
Number of holders
180
Total Shares
139M
Shares change
+30.2M
Total reported value, excl. options
$880M
Value change
+$192M
Put/Call ratio
0.2
Number of buys
103
Number of sells
-71
Price
$6.35
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.